Historical position

Two Sigma Investments, LP’s Charles Riv Labs Intl Inc (CRL) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Two Sigma Investments, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2016Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares285.76KHighest verified quarter-end share count
Quarters reported8Verified quarters with shares above zero
What happened?

Two Sigma Investments, LP first reported Charles Riv Labs Intl Inc in Q1 2016. The reported position was increased and reduced across later filings. Verified positive position history runs through Q4 2022. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q4 2022
Sold 91.8% of the position−114.91K shares · 10.33K shares remained
Filing context

Quarter-end price $217.90

Q3 2022
Sold 56.2% of the position−160.52K shares · 125.24K shares remained
Filing context

Quarter-end price $196.80

Q2 2022
Bought 9.5% more+24.73K shares · 285.76K shares reported after the change
Filing context

Quarter-end price $213.97

Q1 2022
Bought 195.6% more+172.74K shares · 261.03K shares reported after the change
Filing context

Quarter-end price $283.97

Q4 2021
Bought 31.5% more+21.13K shares · 88.29K shares reported after the change
Filing context

Quarter-end price $376.78

Q3 2021
New position+67.16K shares · 67.16K shares reported
Filing context

Quarter-end price $412.67

Portfolio importance

How important was Charles Riv Labs Intl Inc in Two Sigma Investments, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q4 2022
Last reported rank#1270Rank unavailable
Peak portfolio weight0.2%Q1 2022
Best historical rank#112Q1 2022
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$294.442026-09-24

Market context only; not an investor transaction price.

Latest filing quarter-end price$217.90Q4 2022

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Two Sigma’s complete trading book, models, short positions, exact trade dates or execution prices. Options are reported separately.